Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

301

HTML

2564

Figures (1-2)

173

Tables (1-1)

106

Sum=3144

Jul 28, 2008 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 28, 2008; 14(28): 4546-4550
Published online Jul 28, 2008. doi: 10.3748/wjg.14.4546

Table 1 Blood biochemical parameters

Blood samples were obtained 24 h after induction of SAP. Group I: Sham group; Group II: Delayed EP treatment group; Group III: SAP group.

^bP < 0.01 vs Group I;

^dP < 0.01 vs Group II.

Citation: Yang ZY, Ling Y, Yin T, Tao J, Xiong JX, Wu HS, Wang CY. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World J Gastroenterol 2008; 14(28): 4546-4550
URL: https://www.wjgnet.com/1007-9327/full/v14/i28/4546.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4546